Role of blood metabolites in mediating the effect of gut microbiome on the mutated-RAS/BRAF metastatic colorectal cancer-specific survival

Yaoxian Xiang,Chan Zhang,Jing Wang,Yurong Cheng,Kangjie Wang,Li Wang,Yingying Tong,Dong Yan
DOI: https://doi.org/10.1007/s00384-024-04686-9
IF: 2.8
2024-07-26
International Journal of Colorectal Disease
Abstract:Recent studies have linked alterations in the gut microbiome and metabolic disruptions to the invasive behavior and metastasis of colorectal cancer (CRC), thus affecting patient prognosis. However, the specific relationship among gut microbiome, metabolite profiles, and mutated-RAS/BRAF metastatic colorectal cancer (M-mCRC) remains unclear. Furthermore, the potential mechanisms and prognostic implications of metabolic changes induced by gut microbiome alterations in patients with M-mCRC still need to be better understood.
gastroenterology & hepatology,surgery
What problem does this paper attempt to address?